BioPharm International
April 01, 2013
Features
26
4
First gene therapy and plant-based expression vector products approved in 2012.
April 01, 2013
26
4
The author outlines the need for custom-cell products.
April 01, 2013
Manufacturing Best Practices
26
4
Benchmarking can be a useful tool to improve manufacturing practices.
April 01, 2013
Perspectives on Outsourcing
26
4
An innovative approach to capacity management.
April 01, 2013
Compliance Notes
26
4
Have FDA initiatives improved manufacturing quality?
April 01, 2013
Features
26
4
Latin America's diverse growing market seeks regulatory harmonization.
April 01, 2013
26
4
The authors propose a roadmap for analytical lifecycle development.
April 01, 2013
Regulatory Beat
26
4
Opioid abuse generates calls for efforts to curb distribution.
April 01, 2013
Guest Editorial
26
4
Sound policies are needed to govern the substitution of interchangeable biologics.
April 01, 2013
Burrill on Biotech
26
4
Early-stage companies are finding alternatives to venture capital.
April 01, 2013
Boot Camp Tech Guide
26
4
Applications of ZFN technology in biopharmaceutical cell-line engineering.
April 01, 2013
26
4
Ontario-area scientists discuss approaches to development of stem-cell therapies.
April 01, 2013
European Beat
26
4
EU authorities are stepping up their efforts to incorporate QbD principles.
April 01, 2013
Features
26
4
The authors describe the growth characteristics of human mesenchymal stem cells cultured in a stirred-tank bioreactor.
April 01, 2013
Global Reports
26
4
The Thai government is ramping up efforts to promote and develop the biotechnology sector in a bid to enhance its global competitiveness.
April 01, 2013
Issue PDF
26
4
Click the title above to open the BioPharm International April 2013 issue in an interactive PDF format.